首页> 外国专利> anti-cxcr4 antibodies and antibody-drug conjugates, use and methods of producing them, pharmaceutical composition, isolated polynucleotide, vector and isolated host cell

anti-cxcr4 antibodies and antibody-drug conjugates, use and methods of producing them, pharmaceutical composition, isolated polynucleotide, vector and isolated host cell

机译:抗cxcr4抗体和抗体-药物偶联物,用途和生产方法,药物组合物,分离的多核苷酸,载体和分离的宿主细胞

摘要

The present invention relates to antibodies and related molecules that bind to chemokine receptor 4 (cxcr4). The invention further provides antibody-drug conjugates comprising such antibodies, antibody-encoding nucleic acids, vector comprising such nucleic acids, recombinant-producing host cell such antibodies, and methods for obtaining such antibodies. The invention further relates to the use of such antibodies and anti-cxcr4 antibody-drug conjugates for the manufacture of a medicament for the treatment of a disorder associated with the function or expression of cxcr4 (e.g. cancer), such as cancer of cancer. colon, rcc, esophagus, gastric, head and neck, lung, ovarian, pancreatic or hematologic cancers.
机译:本发明涉及结合趋化因子受体4(cxcr4)的抗体和相关分子。本发明进一步提供了包含此类抗体的抗体-药物缀合物,编码抗体的核酸,包含此类核酸的载体,产生重组体的宿主细胞此类抗体,以及获得此类抗体的方法。本发明进一步涉及此类抗体和抗cxcr4抗体-药物缀合物在制备用于治疗与cxcr4的功能或表达相关的病症(例如癌症)的药物中的用途,例如癌症。结肠癌,直肠癌,食道癌,胃癌,头颈癌,肺癌,卵巢癌,胰腺癌或血液学癌症。

著录项

  • 公开/公告号BR122016023010A2

    专利类型

  • 公开/公告日2019-08-27

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号BR20161223010

  • 申请日2014-07-28

  • 分类号A61K39/395;C07K16/28;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号